← FDA Drug Approvals (Drugs@FDA)
NUCALA
BLA · Biologics License Application · Sponsor: GLAXOSMITHKLINE · Approved 2019-06-06
Drug application
- FDA Application #
BLA761122- Application type
- Biologics License Application
- Brand name
- NUCALA
- Generic name
- MEPOLIZUMAB
- Active ingredients
- MEPOLIZUMAB
- Dosage form
- INJECTABLE
- Route
- SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- GLAXOSMITHKLINE
- Manufacturer
- GlaxoSmithKline LLC
- First approval
- 2019-06-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown